Pfizer to Acquire Wyeth, Cut Jobs, Close Sites

Pfizer has agreed to acquire Wyeth for $50.19/share, or a total of about $68 billion, in a deal that the companies say will create one of the most diversified health care firms worldwide. Pfizer also announced plans to lay off 10% of its workforce and close five sites to cut costs. The job cuts will span sales, manufacturing, R&D, and administrative functions. The merger is expected to close in the third or fourth quarter, pending antitrust regulatory approval. Pfizer made the announcements on the same day that it reported net profits down 90%, to $266...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers